Losartan Potassium Tablet, Film Coated
Product Images NDC 71610-083
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 71610-083). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure 3 (Losartan Fig3)
Figure-4 (Losartan Fig4)
This seems to be a table showing the percentage of patients with an event and the risk reduction for a treatment with Losttan Potassium compared to a placebo. The treatment seems to have a risk reduction of 16.1% with a significant p-value of 0.022. However, without additional context, it is difficult to determine what those events and outcomes are.*
Chemical Structure (Losartan Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.